PetVivo Holdings, Inc. (NASDAQ: PETV) (the “Company”) an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for pets is pleased to announce that the Company has changed the brand name of its therapeutic osteoarthritis and lameness product to “SPRYNG”.
“We are incredibly excited to introduce to the world the new brand name for our therapeutic product that squarely addresses the debilitating impact of osteoarthritis and lameness in companion animals.” said John Lai, Chief Executive Officer of PetVivo Holdings, Inc. “The brand name “SPRYNG” clearly illustrates how PetVivo’s product enhances the mobility and overall quality of life in dogs, horses and other animals.”
Spryng™ with OsteoCushion™ Technology is a veterinary medical device comprised of millions of micronized hydrogel matrices, which are derived from the natural components collagen and elastin. OsteoCushion Technology provides both reinforcing natural joint support to replace missing and damaged cartilage as well as delivers natural scaffolding to help the healing of tissue defects. These attributes offer a great solution to the affliction of osteoarthritis for companion animals in a simple in-clinic treatment.
“We believe the brand name “SPRYNG” clearly depicts the beneficial results derived from our therapeutic product administered to animals suffering from osteoarthritis or other lameness afflictions,” said Russ Siakel, Director of Marketing for PetVivo Holdings, Inc. “We have truly witnessed the restoration of a “SPRYNG in the step” of companion animals that have received this life-changing product.”